Global Psilocybin Assisted Therapy Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Psilocybin Assisted Therapy Consumption 2016-2026

2.1.2 Psilocybin Assisted Therapy Consumption CAGR by Region

2.2 Psilocybin Assisted Therapy Segment by Type

2.2.1 Natural

2.2.2 Synthetic

2.3 Psilocybin Assisted Therapy Sales by Type

2.3.1 Global Psilocybin Assisted Therapy Sales Market Share by Type (2016-2021)

2.3.2 Global Psilocybin Assisted Therapy Revenue and Market Share by Type (2016-2021)

2.3.3 Global Psilocybin Assisted Therapy Sale Price by Type (2016-2021)

2.4 Psilocybin Assisted Therapy Segment by Application

2.4.1 Cluster Headaches

2.4.2 Anxiety Disorders

2.4.3 Psychiatric Disorders

2.5 Psilocybin Assisted Therapy Sales by Application

2.5.1 Global Psilocybin Assisted Therapy Sale Market Share by Application (2016-2021)

2.5.2 Global Psilocybin Assisted Therapy Revenue and Market Share by Application (2016-2021)

2.5.3 Global Psilocybin Assisted Therapy Sale Price by Application (2016-2021)

3 Global Psilocybin Assisted Therapy by Company

3.1 Global Psilocybin Assisted Therapy Sales Market Share by Company

3.1.1 Global Psilocybin Assisted Therapy Sales by Company (2019-2021)

3.1.2 Global Psilocybin Assisted Therapy Sales Market Share by Company (2019-2021)

3.2 Global Psilocybin Assisted Therapy Revenue Market Share by Company

3.2.1 Global Psilocybin Assisted Therapy Revenue by Company (2019-2021)

3.2.2 Global Psilocybin Assisted Therapy Revenue Market Share by Company (2019-2021)

3.3 Global Psilocybin Assisted Therapy Sale Price by Company

3.4 Global Manufacturers Psilocybin Assisted Therapy Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Psilocybin Assisted Therapy Product Location Distribution

3.4.2 Players Psilocybin Assisted Therapy Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Psilocybin Assisted Therapy by Region

4.1 Global Psilocybin Assisted Therapy by Region

4.1.1 Global Psilocybin Assisted Therapy Sales by Region

4.1.2 Global Psilocybin Assisted Therapy Revenue by Region

4.2 Americas Psilocybin Assisted Therapy Sales Growth

4.3 APAC Psilocybin Assisted Therapy Sales Growth

4.4 Europe Psilocybin Assisted Therapy Sales Growth

4.5 Middle East & Africa Psilocybin Assisted Therapy Sales Growth

5 Americas

5.1 Americas Psilocybin Assisted Therapy Sales by Country

5.1.1 Americas Psilocybin Assisted Therapy Sales by Country (2016-2021)

5.1.2 Americas Psilocybin Assisted Therapy Revenue by Country (2016-2021)

5.2 Americas Psilocybin Assisted Therapy Sales by Type

5.3 Americas Psilocybin Assisted Therapy Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Psilocybin Assisted Therapy Sales by Region

6.1.1 APAC Psilocybin Assisted Therapy Sales by Region (2016-2021)

6.1.2 APAC Psilocybin Assisted Therapy Revenue by Region (2016-2021)

6.2 APAC Psilocybin Assisted Therapy Sales by Type

6.3 APAC Psilocybin Assisted Therapy Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Psilocybin Assisted Therapy by Country

7.1.1 Europe Psilocybin Assisted Therapy Sales by Country (2016-2021)

7.1.2 Europe Psilocybin Assisted Therapy Revenue by Country (2016-2021)

7.2 Europe Psilocybin Assisted Therapy Sales by Type

7.3 Europe Psilocybin Assisted Therapy Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Psilocybin Assisted Therapy by Country

8.1.1 Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2016-2021)

8.1.2 Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2016-2021)

8.2 Middle East & Africa Psilocybin Assisted Therapy Sales by Type

8.3 Middle East & Africa Psilocybin Assisted Therapy Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Psilocybin Assisted Therapy Distributors

10.3 Psilocybin Assisted Therapy Customer

11 Global Psilocybin Assisted Therapy Market Forecast

11.1 Global Psilocybin Assisted Therapy Forecast by Region

11.1.1 Global Psilocybin Assisted Therapy Forecast by Regions (2021-2026)

11.2.2 Global Psilocybin Assisted Therapy Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Psilocybin Assisted Therapy Forecast by Type

11.7 Global Psilocybin Assisted Therapy Forecast by Application

12 Key Players Analysis

12.1 MindMed

12.1.1 MindMed Company Information

12.1.2 MindMed Psilocybin Assisted Therapy Product Offered

12.1.3 MindMed Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 MindMed Main Business Overview

12.1.5 MindMed Latest Developments

12.2 Compass Pathways

12.2.1 Compass Pathways Company Information

12.2.2 Compass Pathways Psilocybin Assisted Therapy Product Offered

12.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Compass Pathways Main Business Overview

12.2.5 Compass Pathways Latest Developments

12.3 ATAI Life Sciences

12.3.1 ATAI Life Sciences Company Information

12.3.2 ATAI Life Sciences Psilocybin Assisted Therapy Product Offered

12.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 ATAI Life Sciences Main Business Overview

12.3.5 ATAI Life Sciences Latest Developments

12.4 Field Trip

12.4.1 Field Trip Company Information

12.4.2 Field Trip Psilocybin Assisted Therapy Product Offered

12.4.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Field Trip Main Business Overview

12.4.5 Field Trip Latest Developments

12.5 DemeRx

12.5.1 DemeRx Company Information

12.5.2 DemeRx Psilocybin Assisted Therapy Product Offered

12.5.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 DemeRx Main Business Overview

12.5.5 DemeRx Latest Developments

12.6 Eleusis

12.6.1 Eleusis Company Information

12.6.2 Eleusis Psilocybin Assisted Therapy Product Offered

12.6.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Eleusis Main Business Overview

12.6.5 Eleusis Latest Developments

12.7 Hikma Pharmaceuticals PLC

12.7.1 Hikma Pharmaceuticals PLC Company Information

12.7.2 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Offered

12.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Hikma Pharmaceuticals PLC Main Business Overview

12.7.5 Hikma Pharmaceuticals PLC Latest Developments

12.8 Pfizer

12.8.1 Pfizer Company Information

12.8.2 Pfizer Psilocybin Assisted Therapy Product Offered

12.8.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Pfizer Main Business Overview

12.8.5 Pfizer Latest Developments

12.9 Verrian

12.9.1 Verrian Company Information

12.9.2 Verrian Psilocybin Assisted Therapy Product Offered

12.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Verrian Main Business Overview

12.9.5 Verrian Latest Developments

12.10 Jazz Pharmaceuticals

12.10.1 Jazz Pharmaceuticals Company Information

12.10.2 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Offered

12.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Jazz Pharmaceuticals Main Business Overview

12.10.5 Jazz Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

Table 1. Psilocybin Assisted Therapy Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Natural

Table 3. Major Players of Synthetic

Table 4. Global Psilocybin Assisted Therapy Sales by Type (2016-2021) & (K Units)

Table 5. Global Psilocybin Assisted Therapy Sales Market Share by Type (2016-2021)

Table 6. Global Psilocybin Assisted Therapy Revenue by Type (2016-2021) & ($ million)

Table 7. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2016-2021)

Table 8. Global Psilocybin Assisted Therapy Sale Price by Type (2016-2021)

Table 9. Global Psilocybin Assisted Therapy Sales by Application (2016-2021) & (K Units)

Table 10. Global Psilocybin Assisted Therapy Sales Market Share by Application (2016-2021)

Table 11. Global Psilocybin Assisted Therapy Value by Application (2016-2021)

Table 12. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2016-2021)

Table 13. Global Psilocybin Assisted Therapy Sale Price by Application (2016-2021)

Table 14. Global Psilocybin Assisted Therapy Sales by Company (2019-2021) & (K Units)

Table 15. Global Psilocybin Assisted Therapy Sales Market Share by Company (2019-2021)

Table 16. Global Psilocybin Assisted Therapy Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Psilocybin Assisted Therapy Revenue Market Share by Company (2019-2021)

Table 18. Global Psilocybin Assisted Therapy Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Psilocybin Assisted Therapy Producing Area Distribution and Sales Area

Table 20. Players Psilocybin Assisted Therapy Products Offered

Table 21. Psilocybin Assisted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Psilocybin Assisted Therapy Sales by Region (2016-2021) (K Units)

Table 25. Global Psilocybin Assisted Therapy Sales Market Share by Region (2016-2021)

Table 26. Global Psilocybin Assisted Therapy Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2016-2021)

Table 28. Americas Psilocybin Assisted Therapy Sales by Country (2016-2021) & (K Units)

Table 29. Americas Psilocybin Assisted Therapy Sales Market Share by Country (2016-2021)

Table 30. Americas Psilocybin Assisted Therapy Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Psilocybin Assisted Therapy Revenue Market Share by Country (2016-2021)

Table 32. Americas Psilocybin Assisted Therapy Sales by Type (2016-2021) & (K Units)

Table 33. Americas Psilocybin Assisted Therapy Sales Market Share by Type (2016-2021)

Table 34. Americas Psilocybin Assisted Therapy Sales by Application (2016-2021) & (K Units)

Table 35. Americas Psilocybin Assisted Therapy Sales Market Share by Application (2016-2021)

Table 36. APAC Psilocybin Assisted Therapy Sales by Region (2016-2021) & (K Units)

Table 37. APAC Psilocybin Assisted Therapy Sales Market Share by Region (2016-2021)

Table 38. APAC Psilocybin Assisted Therapy Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Psilocybin Assisted Therapy Revenue Market Share by Region (2016-2021)

Table 40. APAC Psilocybin Assisted Therapy Sales by Type (2016-2021) & (K Units)

Table 41. APAC Psilocybin Assisted Therapy Sales Market Share by Type (2016-2021)

Table 42. APAC Psilocybin Assisted Therapy Sales by Application (2016-2021) & (K Units)

Table 43. APAC Psilocybin Assisted Therapy Sales Market Share by Application (2016-2021)

Table 44. Europe Psilocybin Assisted Therapy Sales by Country (2016-2021) & (K Units)

Table 45. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2016-2021)

Table 46. Europe Psilocybin Assisted Therapy Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Psilocybin Assisted Therapy Revenue Market Share by Country (2016-2021)

Table 48. Europe Psilocybin Assisted Therapy Sales by Type (2016-2021) & (K Units)

Table 49. Europe Psilocybin Assisted Therapy Sales Market Share by Type (2016-2021)

Table 50. Europe Psilocybin Assisted Therapy Sales by Application (2016-2021) & (K Units)

Table 51. Europe Psilocybin Assisted Therapy Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Psilocybin Assisted Therapy Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Psilocybin Assisted Therapy Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Psilocybin Assisted Therapy

Table 61. Key Application and Potential Industries of Psilocybin Assisted Therapy

Table 62. Key Challenges of Psilocybin Assisted Therapy

Table 63. Key Trends of Psilocybin Assisted Therapy

Table 64. Psilocybin Assisted Therapy Distributors List

Table 65. Psilocybin Assisted Therapy Customer List

Table 66. Global Psilocybin Assisted Therapy Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Psilocybin Assisted Therapy Consumption Market Forecast by Region

Table 68. Global Psilocybin Assisted Therapy Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Psilocybin Assisted Therapy Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Psilocybin Assisted Therapy Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Psilocybin Assisted Therapy Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Psilocybin Assisted Therapy Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Psilocybin Assisted Therapy Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Psilocybin Assisted Therapy Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Psilocybin Assisted Therapy Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Psilocybin Assisted Therapy Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Psilocybin Assisted Therapy Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Psilocybin Assisted Therapy Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Psilocybin Assisted Therapy Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Psilocybin Assisted Therapy Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Psilocybin Assisted Therapy Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Psilocybin Assisted Therapy Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Application (2021-2026)

Table 86. MindMed Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 87. MindMed Psilocybin Assisted Therapy Product Offered

Table 88. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. MindMed Main Business

Table 90. MindMed Latest Developments

Table 91. Compass Pathways Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 92. Compass Pathways Psilocybin Assisted Therapy Product Offered

Table 93. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Compass Pathways Main Business

Table 95. Compass Pathways Latest Developments

Table 96. ATAI Life Sciences Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 97. ATAI Life Sciences Psilocybin Assisted Therapy Product Offered

Table 98. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. ATAI Life Sciences Main Business

Table 100. ATAI Life Sciences Latest Developments

Table 101. Field Trip Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 102. Field Trip Psilocybin Assisted Therapy Product Offered

Table 103. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Field Trip Main Business

Table 105. Field Trip Latest Developments

Table 106. DemeRx Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 107. DemeRx Psilocybin Assisted Therapy Product Offered

Table 108. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. DemeRx Main Business

Table 110. DemeRx Latest Developments

Table 111. Eleusis Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 112. Eleusis Psilocybin Assisted Therapy Product Offered

Table 113. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. Eleusis Main Business

Table 115. Eleusis Latest Developments

Table 116. Hikma Pharmaceuticals PLC Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 117. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Offered

Table 118. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. Hikma Pharmaceuticals PLC Main Business

Table 120. Hikma Pharmaceuticals PLC Latest Developments

Table 121. Pfizer Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 122. Pfizer Psilocybin Assisted Therapy Product Offered

Table 123. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. Pfizer Main Business

Table 125. Pfizer Latest Developments

Table 126. Verrian Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 127. Verrian Psilocybin Assisted Therapy Product Offered

Table 128. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. Verrian Main Business

Table 130. Verrian Latest Developments

Table 131. Jazz Pharmaceuticals Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors

Table 132. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Offered

Table 133. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. Jazz Pharmaceuticals Main Business

Table 135. Jazz Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Psilocybin Assisted Therapy

Figure 2. Psilocybin Assisted Therapy Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Psilocybin Assisted Therapy Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Psilocybin Assisted Therapy Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Psilocybin Assisted Therapy Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Natural

Figure 10. Product Picture of Synthetic

Figure 11. Global Psilocybin Assisted Therapy Sales Market Share by Type in 2020

Figure 12. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2016-2021)

Figure 13. Psilocybin Assisted Therapy Consumed in Cluster Headaches

Figure 14. Global Psilocybin Assisted Therapy Market: Cluster Headaches (2016-2021) & (K Units)

Figure 15. Psilocybin Assisted Therapy Consumed in Anxiety Disorders

Figure 16. Global Psilocybin Assisted Therapy Market: Anxiety Disorders (2016-2021) & (K Units)

Figure 17. Psilocybin Assisted Therapy Consumed in Psychiatric Disorders

Figure 18. Global Psilocybin Assisted Therapy Market: Psychiatric Disorders (2016-2021) & (K Units)

Figure 19. Global Psilocybin Assisted Therapy Sales Market Share by Application (2016-2021)

Figure 20. Global Psilocybin Assisted Therapy Revenue Market Share by Application in 2020

Figure 21. Psilocybin Assisted Therapy Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Psilocybin Assisted Therapy Revenue Market Share by Company in 2020

Figure 23. Global Psilocybin Assisted Therapy Sales Market Share by Regions (2016-2021)

Figure 24. Global Psilocybin Assisted Therapy Revenue Market Share by Region in 2020

Figure 25. Americas Psilocybin Assisted Therapy Sales 2016-2021 (K Units)

Figure 26. Americas Psilocybin Assisted Therapy Revenue 2016-2021 ($ Millions)

Figure 27. APAC Psilocybin Assisted Therapy Sales 2016-2021 (K Units)

Figure 28. APAC Psilocybin Assisted Therapy Revenue 2016-2021 ($ Millions)

Figure 29. Europe Psilocybin Assisted Therapy Sales 2016-2021 (K Units)

Figure 30. Europe Psilocybin Assisted Therapy Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Psilocybin Assisted Therapy Sales 2016-2021 (K Units)

Figure 32. Middle East & Africa Psilocybin Assisted Therapy Revenue 2016-2021 ($ Millions)

Figure 33. Americas Psilocybin Assisted Therapy Sales Market Share by Country in 2020

Figure 34. Americas Psilocybin Assisted Therapy Revenue Market Share by Country in 2020

Figure 35. Americas Psilocybin Assisted Therapy Sales Market Share by Type in 2020

Figure 36. Americas Psilocybin Assisted Therapy Sales Market Share by Application in 2020

Figure 37. United States Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Psilocybin Assisted Therapy Sales Market Share by Region in 2020

Figure 42. APAC Psilocybin Assisted Therapy Revenue Market Share by Regions in 2020

Figure 43. APAC Psilocybin Assisted Therapy Sales Market Share by Type in 2020

Figure 44. APAC Psilocybin Assisted Therapy Sales Market Share by Application in 2020

Figure 45. China Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Psilocybin Assisted Therapy Sales Market Share by Country in 2020

Figure 52. Europe Psilocybin Assisted Therapy Revenue Market Share by Country in 2020

Figure 53. Europe Psilocybin Assisted Therapy Sales Market Share by Type in 2020

Figure 54. Europe Psilocybin Assisted Therapy Sales Market Share by Application in 2020

Figure 55. Germany Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Application in 2020

Figure 64. Egypt Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Psilocybin Assisted Therapy Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles